Events
Karolinska Development AB announces that The Board of Directors has decided to delay the publication of its Annual Report for 2018.
Bringing Attention to Malaria Vaccine Development Efforts
At the Annual General Meeting of Immunicum AB (publ), reg. no 556629-1786, on April 25, 2019 the AGM adopted, inter alia, the following resolutions.
Assertio Therapeutics, Inc. announced that it will release first quarter 2019 financial results on Wednesday, May 8, 2019, after the close of markets.
Accenture recently published a new report, “New Science: Biopharma’s New Growth Machine.” In it, the report attempts to evaluate the last 20 years of trends in biopharma and use that data to develop projections for the future of the industry.
Retrophin, Inc. announced it will report first quarter 2019 financial results on Tuesday, May 7, 2019 after the close of the U.S. financial markets.
Dr. Revah will join fellow industry panelists at the Cell and Gene Meeting on the Med in Barcelona to discuss strategies for gene therapy manufacturing, on April 23rd
The IQVIA Institute for Human Data Science released a new report titled, “The Changing Landscape of Research and Development: Innovation, Drivers of Change, and Evolution of Clinical Trial Productivity.”
TLC announced that the company’s management team will be presenting at the following conferences
The California life Sciences Institutes (CLSI) recently named the winners of the 2019 Amgen Bay Area BioGENEius Challenge. This challenge is a Bay Area competition for high school students that focuses on the students’ individual research projects in the life sciences.Lori Lindburg, president and chief executive officer of CLSI, took time to speak with BioSpace about the organization and the Challenge.
PRESS RELEASES